company background image
5004

Abbott IndiaBSE:500488 Stock Report

Market Cap

₹405.9b

7D

-3.3%

1Y

24.0%

Updated

30 Nov, 2021

Data

Company Financials
500488 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends4/6

500488 Stock Overview

Abbott India Limited operates as a pharmaceutical company in India.

Rewards

Earnings have grown 20.6% per year over the past 5 years

Pays a reliable dividend of 1.44%

Risk Analysis

No risks detected for 500488 from our risk checks.

Abbott India Competitors

Sun Pharmaceutical Industries

NSEI:SUNPHARMA

₹1.8t

Cipla

NSEI:CIPLA

₹783.6b

Dr. Reddy's Laboratories

BSE:500124

₹776.6b

Torrent Pharmaceuticals

BSE:500420

₹515.0b

Price History & Performance

Summary of all time highs, changes and price drops for Abbott India
Historical stock prices
Current Share Price₹19,100.10
52 Week High₹23,902.30
52 Week Low₹13,970.10
Beta-0.11
1 Month Change-4.59%
3 Month Change-4.69%
1 Year Change24.04%
3 Year Change146.41%
5 Year Change296.63%
Change since IPO3,250.90%

Recent News & Updates

Shareholder Returns

500488IN PharmaceuticalsIN Market
7D-3.3%2.2%-1.7%
1Y24.0%15.2%42.2%

Return vs Industry: 500488 exceeded the Indian Pharmaceuticals industry which returned 15.2% over the past year.

Return vs Market: 500488 underperformed the Indian Market which returned 42.2% over the past year.

Price Volatility

Is 500488's price volatile compared to industry and market?
500488 volatility
500488 Average Weekly Movement5.2%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market3.8%

Stable Share Price: 500488 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 500488's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19443,585Anil Josephhttps://www.abbott.co.in

Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women’s health, gastroenterology, metabolic, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India.

Abbott India Fundamentals Summary

How do Abbott India's earnings and revenue compare to its market cap?
500488 fundamental statistics
Market Cap₹405.86b
Earnings (TTM)₹7.18b
Revenue (TTM)₹46.31b

56.6x

P/E Ratio

8.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
500488 income statement (TTM)
Revenue₹46.31b
Cost of Revenue₹25.48b
Gross Profit₹20.83b
Expenses₹13.65b
Earnings₹7.18b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)337.75
Gross Margin44.98%
Net Profit Margin15.50%
Debt/Equity Ratio0%

How did 500488 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

36%

Payout Ratio

Valuation

Is Abbott India undervalued compared to its fair value and its price relative to the market?

56.55x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 500488 (₹19100.1) is trading above our estimate of fair value (₹17127.75)

Significantly Below Fair Value: 500488 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 500488 is poor value based on its PE Ratio (56.6x) compared to the Indian Pharmaceuticals industry average (21.6x).

PE vs Market: 500488 is poor value based on its PE Ratio (56.6x) compared to the Indian market (18.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 500488's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 500488 is overvalued based on its PB Ratio (16.8x) compared to the IN Pharmaceuticals industry average (2.8x).


Future Growth

How is Abbott India forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

20.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Abbott India has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Abbott India performed over the past 5 years?

20.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 500488 has high quality earnings.

Growing Profit Margin: 500488's current net profit margins (15.5%) are lower than last year (15.8%).


Past Earnings Growth Analysis

Earnings Trend: 500488's earnings have grown significantly by 20.6% per year over the past 5 years.

Accelerating Growth: 500488's earnings growth over the past year (9%) is below its 5-year average (20.6% per year).

Earnings vs Industry: 500488 earnings growth over the past year (9%) underperformed the Pharmaceuticals industry 30.2%.


Return on Equity

High ROE: 500488's Return on Equity (29.8%) is considered high.


Financial Health

How is Abbott India's financial position?


Financial Position Analysis

Short Term Liabilities: 500488's short term assets (₹33.3B) exceed its short term liabilities (₹10.9B).

Long Term Liabilities: 500488's short term assets (₹33.3B) exceed its long term liabilities (₹2.2B).


Debt to Equity History and Analysis

Debt Level: 500488 is debt free.

Reducing Debt: 500488 had no debt 5 years ago.

Debt Coverage: 500488 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 500488 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Abbott India current dividend yield, its reliability and sustainability?

1.44%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 500488's dividend (1.44%) is higher than the bottom 25% of dividend payers in the Indian market (0.37%).

High Dividend: 500488's dividend (1.44%) is low compared to the top 25% of dividend payers in the Indian market (1.51%).


Stability and Growth of Payments

Stable Dividend: 500488's dividends per share have been stable in the past 10 years.

Growing Dividend: 500488's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (35.5%), 500488's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.6yrs

Average board tenure


CEO

Anil Joseph (46 yo)

1.33yrs

Tenure

₹38,000,000

Compensation

Mr. Anil Joseph serves as Managing Director and Director at Abbott India Limited since July 01, 2020. He worked with reputable companies across different business sectors (predominately Healthcare & FMCG)...


CEO Compensation Analysis

Compensation vs Market: Anil's total compensation ($USD505.91K) is below average for companies of similar size in the Indian market ($USD892.88K).

Compensation vs Earnings: Insufficient data to compare Anil's compensation with company performance.


Board Members

Experienced Board: 500488's board of directors are considered experienced (3.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Abbott India Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Abbott India Limited
  • Ticker: 500488
  • Exchange: BSE
  • Founded: 1944
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹405.864b
  • Shares outstanding: 21.25m
  • Website: https://www.abbott.co.in

Number of Employees


Location

  • Abbott India Limited
  • Godrej BKC
  • 16th Floor, Plot C, “G” Block
  • Mumbai
  • Maharashtra
  • 400051
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/30 15:56
End of Day Share Price2021/11/30 00:00
Earnings2021/09/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.